Redefining FOLFIORINOX in Older Pancreatic Cancer Patients
Clinical trial NCT05360732 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05360732
- Sponsor
- Fox Chase Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-22
- Primary completion
- 2026-09-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.